A Dose Escalation Study of AV-380 in Cancer Patients With Cachexia
Clinical trial NCT05865535 · RECRUITING
Trial details
- NCT number
- NCT05865535
- Sponsor
- AVEO Pharmaceuticals, Inc.
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-06-13
- Primary completion
- 2026-12-01
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.